Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

733 ARTÍCULOS , VIENDO DEL 661 AL 675

Patient Preferences for Dementia Interventions: A Scoping Review With a Systematic Review of Medications and Choice-Based Methods

Gupta R, Lin S, DiStefano MJ, Woo HYJ, Mao E, Wilson R, Amjad H, Drabo EF, Segal JB.

J Am Geriatr Soc. 2026 Mar;74(3):868-882. doi: 10.1111/jgs.70209. Epub 2025 Nov 26.

Design strategies, structural insights, and biological potential of amyloid-beta inhibitors in Alzheimer's disease

Guleria M, Malhan A, Teli G, Bisht N, Jain SK.

Mol Divers. 2026 Feb;30(1):273-298. doi: 10.1007/s11030-025-11278-4. Epub 2025 Jul 3.

A Narrative Review on the Neuroprotective Effects of Selenium and Vitamin D in Alzheimer's Disease

Bragais EK, Luna KLD, Timoteo-Garcia VJ.

Biol Trace Elem Res. 2026 Mar;204(3):1848-1865. doi: 10.1007/s12011-025-04788-7. Epub 2025 Aug 14.

Nanotechnology-driven approaches for the early detection and targeted treatment of Alzheimer's disease

Sharma DK.

J Drug Target. 2026 Mar;34(3):372-389. doi: 10.1080/1061186X.2025.2561788. Epub 2025 Sep 19.

Exploring Autophagy Inducing Molecules: Targeting Diverse Pathways in Alzheimer's Disease Management

Singh B, Mahajan S, Abdella S, Khan R, Garg S.

Med Res Rev. 2026 Jan;46(1):272-298. doi: 10.1002/med.70013. Epub 2025 Sep 29.

Microbiota-gut-brain axis and probiotics: potential therapeutic strategies for treating Alzheimer's disease

Ajith TA, Sreejith JK.

Nutr Neurosci. 2026 Mar;29(3):410-426. doi: 10.1080/1028415X.2025.2567429. Epub 2025 Oct 11.

The therapeutic efficacy of nanoparticles in the treatment of alzheimer's disease

Ntondini TL, Naki T, Alven S.

Acta Neurol Belg. 2026 Feb;126(1):35-53. doi: 10.1007/s13760-025-02905-w. Epub 2025 Oct 13.

Behavioral dyadic interventions in the context of Alzheimer's disease and related dementia: A call to action

Vranceanu AM, Szapary CL, Cornelius T, Monin JK, Syme M, Okereke OI, Lyons KS, Plys E.

J Alzheimers Dis. 2026 Jan;109(1):34-43. doi: 10.1177/13872877251392184. Epub 2025 Nov 10.

Pharmacological Regulation of Mitophagy by Natural Plant Products as a Therapeutic Target for Alzheimer's Disease

Shao S, Lu H, Zu R, Chen Y, Peng Z, Peng Q, Ma H, Sun Y.

Phytother Res. 2026 Jan;40(1):248-266. doi: 10.1002/ptr.70131. Epub 2025 Nov 21.

Pharmacological modulation of the PI3K/AKT/GSK3β axis: a new frontier in Alzheimer's disease treatment

Alqahtani SM, Al-Kuraishy HM, Al-Gareeb AI, Albuhadily AK, Shokr MM, Alexiou A, Papadakis M, Batiha GE.

Inflammopharmacology. 2026 Jan;34(1):267-283. doi: 10.1007/s10787-025-02000-9. Epub 2025 Nov 26.

Sirtuins in Alzheimer's disease: mechanistic insights and therapeutic opportunities

Bai N, Liu S, Wei J, Zheng B, Wang W, Li X, Yang J, Song X, Wang L, Yi F, Cao L.

Trends Pharmacol Sci. 2026 Jan;47(1):100-119. doi: 10.1016/j.tips.2025.10.016. Epub 2025 Nov 26.

Targeting protein kinase C signaling cascades in alzheimer's disease: emerging neuroprotective roles of aurothioglucose

Kushawaha SK, Vashisht K, Kumar H, Ashawat MS, Baldi A.

Inflammopharmacology. 2026 Jan;34(1):243-254. doi: 10.1007/s10787-025-02077-2. Epub 2025 Dec 3.

The therapeutic potential of early exercise in Alzheimer's disease: Focus on the brain-spleen axis

Wang T, Feng L, Tian Z.

Ageing Res Rev. 2026 Jan;114:102980. doi: 10.1016/j.arr.2025.102980. Epub 2025 Dec 1.

Neuroprotective potential of Rhus coriaria: Insights into acetylcholinesterase inhibition and amyloid-β modulation

Ahmed A, Khan H, Shen Y, Xu S, Zhao Y, Lv J, Zhu X, Fu X, Li P.

J Alzheimers Dis. 2026 Feb;109(3):1053-1067. doi: 10.1177/13872877251404020. Epub 2025 Dec 15.

Induced-pluripotent stem cell-derived immunotherapy for Tau and Alzheimer's disease

Chinnathambi S.

Adv Protein Chem Struct Biol. 2026;151:197-224. doi: 10.1016/bs.apcsb.2025.10.005. Epub 2025 Nov 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias